$KITT
Nauticus Robotics, Inc. Stock $kitt

$kitt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023039981 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.128M	$2.821M	$0.00
YoY Change
Cost Of Revenue	$1.901M	$2.932M	$1.899M
YoY Change	-25.17%	54.4%
Gross Profit	-$772.5K	-$111.5K	-$1.899M
YoY Change	-69.59%	-94.13%
Gross Profit Margin	-68.48%	-3.95%
Selling, General & Admin	$5.560M	$5.210M	$20.73K
YoY Change	7212.9%	25032.66%
% of Gross Profit
Research & Development	$482.8K	$227.0K	$1.267M
YoY Change	-17.32%	-82.09%
% of Gross Profit
Depreciation & Amortization	$60.00K	$273.1K	$111.3K
YoY Change		145.33%
% of Gross Profit
Operating Expenses	$482.8K	$227.0K	$479.4K
YoY Change	-68.29%	-52.65%
Operating Profit	-$6.869M	-$5.824M	-$2.688M
YoY Change	351.17%	116.68%
Interest Expense	-$1.540M	-$4.930M	$2.431M
YoY Change	-308.38%	-302.79%
% of Operating Profit
Other Income/Expense, Net	$27.54M	-$4.356M	-$816.0K
YoY Change	-3401.03%	433.78%
Pretax Income	$20.67M	-$14.14M	$1.952M
YoY Change	-2738.26%	-824.51%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	$20.67M	-$10.18M	$1.952M
YoY Change	-2697.72%	-621.61%
Net Earnings / Revenue	1832.56%	-360.89%
Basic Earnings Per Share	$0.52	-$0.26	-$0.36
Diluted Earnings Per Share	$0.49	-$0.26	$90.51K
COMMON SHARES
Basic Shares Outstanding	47.51M shares	47.28M shares	9.669M shares
Diluted Shares Outstanding	44.35M shares	39.77M shares	9.669M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.400M	$12.50M	$296.4K
YoY Change	-97.48%	4117.56%	1085.52%
Cash & Equivalents	$4.353M	$12.48M	$15.08M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$53.61K	$54.38K	$44.99K
YoY Change	77.74%	20.88%
Inventory	$12.54M	$11.01M
Prepaid Expenses	$6.121M	$5.393M
Receivables	$1.302M	$2.635M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$25.23M	$32.15M	$341.4K
YoY Change	12331.1%	9317.31%	1265.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.78M	$16.95M
YoY Change	249.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$129.4K	$140.2K	$174.2M
YoY Change	-99.93%	-99.92%	135850.67%
Total Long-Term Assets	$23.30M	$17.35M	$174.2M
YoY Change	-86.65%	-90.04%	135850.67%
TOTAL ASSETS
Total Short-Term Assets	$25.23M	$32.15M	$341.4K
Total Long-Term Assets	$23.30M	$17.35M	$174.2M
Total Assets	$48.53M	$49.49M	$174.6M
YoY Change	-72.22%	-71.65%	113884.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.732M	$2.607M	$178.3K
YoY Change	1661.52%	1362.33%
Accrued Expenses	$7.310M	$3.656M	$92.33K
YoY Change	617.39%	3860.0%	-28.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$267.0K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.57M	$6.611M	$561.6K
YoY Change	592.84%	1077.18%	334.78%
LONG-TERM LIABILITIES
Long-Term Debt	$17.80M	$16.83M	$0.00
YoY Change
Other Long-Term Liabilities	$5.847M	$34.93M	$5.560M
YoY Change	15.65%	528.18%
Total Long-Term Liabilities	$23.65M	$51.76M	$5.560M
YoY Change	367.71%	830.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.57M	$6.611M	$561.6K
Total Long-Term Liabilities	$23.65M	$51.76M	$5.560M
Total Liabilities	$38.21M	$58.37M	$6.121M
YoY Change	444.71%	853.59%	4639.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.57M	-$78.29M
YoY Change	819.08%
Common Stock	$4.789K	$4.728K
YoY Change	1011.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.32M	-$8.878M	-$5.757M
YoY Change
Total Liabilities & Shareholders Equity	$48.53M	$49.49M	$174.6M
YoY Change	-72.22%	-71.65%	113884.04%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$20.67M	-$10.18M	$1.952M
YoY Change	-2697.72%	-621.61%
Depreciation, Depletion And Amortization	$60.00K	$273.1K	$111.3K
YoY Change		145.33%
Cash From Operating Activities	-$4.140M	-$8.833M	-$489.5K
YoY Change	1511.33%	1704.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$4.610M	$3.470M
YoY Change
Cash From Investing Activities	-$4.610M	$3.465M	-$1.675M
YoY Change		-306.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	620.0K	$59.19K	267.0K
YoY Change	365.01%	-77.83%
NET CHANGE
Cash From Operating Activities	-4.140M	-$8.833M	-489.5K
Cash From Investing Activities	-4.610M	$3.465M	-$1.675M
Cash From Financing Activities	620.0K	$59.19K	267.0K
Net Change In Cash	-8.130M	-$5.309M	-222.5K
YoY Change	6477.67%	2285.73%
FREE CASH FLOW
Cash From Operating Activities	-$4.140M	-$8.833M	-$489.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40611
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1699753
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	17146 FEATHERCRAFT LANE
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 450
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	WEBSTER
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77598
CY2023Q1	dei	City Area Code CityAreaCode	(281)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	942-9069
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47507796	shares
CY2023Q1	us-gaap	Cash Cash	12478433	usd
CY2022Q4	us-gaap	Cash Cash	17787159	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	250375	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	250375	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	4959263	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2634644	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1622434	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69402246	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68128196	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	11013569	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6666912	usd
CY2023Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	323931	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	573895	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5392527	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5046599	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	54384	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56410	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	32147863	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	36963047	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16950015	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15167367	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	256389	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317208	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	140197	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155490	usd
CY2023Q1	us-gaap	Assets Assets	49494464	usd
CY2022Q4	us-gaap	Assets Assets	52603112	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2607473	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	324484	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3656268	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3142977	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347392	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	410158	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6611133	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3877619	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34925245	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32688342	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6251	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87214	usd
CY2023Q1	kitt	Notes Payable Longterm Net Of Discount NotesPayableLongtermNetOfDiscount	16829983	usd
CY2022Q4	kitt	Notes Payable Longterm Net Of Discount NotesPayableLongtermNetOfDiscount	15922118	usd
CY2023Q1	us-gaap	Liabilities Liabilities	58372612	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52575293	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	625000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	625000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47281275	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47250771	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47281275	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47250771	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	4728	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4725	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78285122	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68105102	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-8878148	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49494464	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52603112	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2820780	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2235965	usd
CY2023Q1	us-gaap	Revenues Revenues	2820780	usd
CY2022Q1	us-gaap	Revenues Revenues	2235965	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2932267	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1899161	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	273099	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	111319	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	226967	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1267412	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5212644	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1646041	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	8644977	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	4923933	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5824197	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2687968	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1152381	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4212	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9884	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9848	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2236904	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-976422	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-801974	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4355823	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-816034	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10180020	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3504002	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39765361	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9669217	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6611457	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	200157	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3504002	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-9915302	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27819	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1214863	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	59190	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10180020	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-8878148	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10180020	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3504002	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	273099	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	111319	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	907865	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	171979	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1214863	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	200157	usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	2236904	usd
CY2023Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	60819	usd
CY2022Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	32325	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1012210	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	211779	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4346657	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	721042	usd
CY2023Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-249964	usd
CY2022Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-300616	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	328609	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	577901	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2234510	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	436412	usd
CY2022Q1	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-373791	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	143729	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	64543	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8833201	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4200250	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1493978	usd
CY2022Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1675238	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4959263	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3465285	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1675238	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	59190	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	59190	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5308726	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5875488	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17787159	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20952867	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12478433	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15077379	usd
CY2023Q1	kitt	Loan Commitment Fee LoanCommitmentFee	469850	usd
CY2022Q1	kitt	Loan Commitment Fee LoanCommitmentFee	322067	usd
CY2023Q1	kitt	Shares Issued Description SharesIssuedDescription	follows (i) an aggregate of 36,650,778 shares of Common Stock, par value $0.0001 (the “Common Stock” of CLAQ prior to the Closing, and the Common Stock of Nauticus following the Closing) shares were issued to holders of Nauticus Common Stock in the Business Combination (ii) the right to receive 7,499,993 additional shares of Common Stock held in escrow pursuant to the terms of the Merger Agreement and as further described below (such additional escrowed shares, the “Earnout Shares”) and (iii) the issuance of 3,100,000 shares of Common Stock for the Equity Financing (as described below). An aggregate of 47,250,771 shares of Common Stock (inclusive of the Earnout Shares) was issued after the Business Combination.
CY2023Q1	kitt	Additional Share Of Common Stock AdditionalShareOfCommonStock	7499993	shares
CY2023Q1	us-gaap	Intercompany Agreements Description IntercompanyAgreementsDescription	i.one-half of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period; ii.one-quarter of the Earnout Shares will be released if, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and iii.one-quarter of the Earnout Shares will be released if, on or after December 31, 2022, within a 5-year period from Closing Date, the volume-weighted average price of our Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period.
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	3100000	shares
CY2023Q1	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	10
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	31000000	usd
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	36530320	usd
CY2022Q3	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	14947875	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	30157	usd
CY2022Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	14796942	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	850333	usd
CY2022Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-669243	usd
CY2023Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	14947875	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	12582000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Use of Estimates</i> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) estimates of future costs to complete customer contracts recognized over time, (ii) valuation allowances for deferred income tax assets, (iii) valuation of stock-based compensation awards and (iv) the valuation of conversion options, warrants and earnouts. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	250000	usd
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	4959263	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reclassifications</i> – Financial statements presented for prior periods include reclassifications that were made to conform to the current-period presentation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1302500	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1499030	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	9711069	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5167882	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	11013569	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	6666912	usd
CY2023Q1	kitt	Recognized Income Tax RecognizedIncomeTax	0.50	pure
CY2023Q1	us-gaap	Cash Held In Foreign Currency CashHeldInForeignCurrency	9884	usd
CY2022Q1	us-gaap	Cash Held In Foreign Currency CashHeldInForeignCurrency	9848	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	234985	usd
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	34467	usd
CY2023Q1	kitt	Total Balance Percentage TotalBalancePercentage	0.02	pure
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.99	pure
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.99	pure
CY2022	kitt	Customer Percentage CustomerPercentage	0.10	pure
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Accounting Pronouncements – </i>In September 2022, the FASB issued ASU 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-60): Disclosure of Supplier Finance Program Obligations, which requires companies to disclose the use and impact of such programs on a company’s working capital, liquidity, and cash flow. We adopted this standard on January 1, 2023. We do not utilize Supplier Finance Programs and therefore no further disclosure is required. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU No. 2016-13, an amendment to ASC 326, <i>Financial Instruments - Credit Losses</i>, which changes the impairment model for certain financial assets that have a contractual right to receive cash, including trade and loan receivables. The new model requires recognition based upon an estimation of expected credit losses rather than recognition of losses when it is probable that they have been incurred. An entity will apply the amendment through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company has adopted this standard as of January 1, 2023 and there was no impact on its financial position, results of operations and cash flows upon adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2022, the FASB issued ASU No. 2022-02, an amendment to ASC 326, <i>Financial Instruments-Credit Losses</i>, which eliminates the accounting guidance for creditors in troubled debt restructuring. It also aligns conflicting disclosure requirement guidance in ASC 326 by requiring disclosure of current-period gross write-offs by year of origination. The amendment also adds new disclosures for creditors with loan refinancing and restructuring for borrowers experiencing financial difficulty. The Company has adopted this standard as of January 1, 2023 and there was no impact on its financial position, results of operations and cash flows upon adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no other new accounting pronouncements that are expected to have a material impact on our condensed consolidated financial statements.</p>
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2820780	usd
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2235965	usd
CY2023Q1	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	2634644	usd
	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	2634644	usd
CY2022	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	1622434	usd
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	9963	usd
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	9963	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2022Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	0	usd
CY2023Q1	us-gaap	Contract With Customer Asset Sale ContractWithCustomerAssetSale	249944	usd
CY2023Q1	kitt	Revenue Recognize RevenueRecognize	8200000	usd
CY2023Q1	kitt	Contract Receivable Retainages Due One To Two Years ContractReceivableRetainagesDueOneToTwoYears	8.2	usd
CY2023Q1	kitt	Contract Receivable Retainages Due Two To Three Years ContractReceivableRetainagesDueTwoToThreeYears	1.2	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	7	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	590936	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1294305	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	171660	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	75702	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	84624	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3268126	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2454298	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1760203	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2392978	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	364198	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	199323	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	5392527	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	5046599	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2276524	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2003341	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	14981373	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	12974361	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	16950015	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	15167367	usd
CY2023Q1	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	532973	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	1501736	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1390130	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	794021	usd
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	363158	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3656268	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3142977	usd
CY2023Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	1200000	usd
CY2023Q1	kitt	Convertible Secured Debentures ConvertibleSecuredDebentures	36530320	usd
CY2022	kitt	Convertible Secured Debentures ConvertibleSecuredDebentures	36530320	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	36530320	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	36530320	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-19700337	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-20608202	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	16829983	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15922118	usd
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	36530320	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2922425	shares
CY2023Q1	kitt	Inclusive Proceeds InclusiveProceeds	35800000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.02	pure
CY2023Q1	kitt	Fair Value Debenture Warrants FairValueDebentureWarrants	20949110	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	21679716	usd
CY2023Q1	kitt	The Debentures Converted Description TheDebenturesConvertedDescription	The Debentures may be converted at each holder’s option at 120% of the principal amount at a conversion price of $15.00 or 2,922,425 shares of Common Stock. The conversion price may be adjusted downward for certain events including the issuance by the Company of dilutive instruments below the current conversion price. Interest accrues on the outstanding principal amount of the Debentures at 5% per annum, payable quarterly.
CY2023Q1	kitt	Exercisable Initially Par Share ExercisableInitiallyParShare	20
CY2023Q1	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	907865	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Basis For Effective Rate DebtInstrumentInterestRateBasisForEffectiveRate	25.2%
CY2023Q1	kitt	Matures Date MaturesDate	2024-04-30
CY2023Q1	kitt	Discount Interest Rate DiscountInterestRate	0.08	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	46194	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	56634	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	90544	usd
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	90248	usd
CY2023Q1	kitt	Right Of Use Asset Lease Liability Percentage RightOfUseAssetLeaseLiabilityPercentage	0.0775	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	102969	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	69191	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	8935	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	44508	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	111904	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	113699	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	7499993	shares
CY2023Q1	kitt	Private Warrants Shares PrivateWarrantsShares	8625000	shares
CY2023Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.01
CY2023Q1	kitt	Common Stock Exceeds Price CommonStockExceedsPrice	16.5
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	11.5
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	1653223	usd
CY2023Q1	kitt	Private Warrants Description PrivateWarrantsDescription	The fair value of the Private Warrants was estimated using a Black-Scholes option pricing model using the following assumptions: stock price of $2.98, no assumed dividends, a risk-free rate of 3.66% and implied volatility of 44.6%. The change in value of the Private Warrants during the three months ended March 31, 2023 totaled $(281,362) and was reported with other (income) expense in our condensed consolidated statements of operations.
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2837513	usd
CY2023Q1	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	7950951	shares
CY2023Q1	kitt	Business Combination Shares BusinessCombinationShares	279464	shares
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	3970266	shares
CY2023Q1	kitt	Continuous Service Percentage ContinuousServicePercentage	0.25	pure
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1282580	usd
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y5M1D
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	14.2069	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M9D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	54687	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	3837080	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	2607385	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2778152	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1735720	usd
CY2023Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Tax Benefit ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit	11859	usd
CY2022Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Tax Benefit ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit	0	usd
CY2023Q1	kitt	Vested Percentage VestedPercentage	0.50	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3134677	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.73
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	48274	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.48
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	13682	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.73
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3169269	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.71
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	9428576	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y3M25D
CY2023Q1	kitt	Employees Gross Salaries Percentage EmployeesGrossSalariesPercentage	0.03	pure
CY2023Q1	us-gaap	Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1 PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1	117342	usd
CY2022Q1	us-gaap	Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1 PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1	78190	usd
CY2023Q1	kitt	Debentures Shares DebenturesShares	2922425	shares
CY2023Q1	kitt	Total Shares TotalShares	35786241	shares
CY2022Q1	kitt	Total Shares TotalShares	9305263	shares
CY2023Q1	kitt	Investment And Securities Description InvestmentAndSecuritiesDescription	(i) $2,500,000 from related party Material Impact Fund II, L.P. as their contribution to the PIPE Investment, (ii) $7,500,000 from related party Schlumberger Technology Corporation as their contribution to the PIPE Investment, (iii) $7,500,000 from related party Transocean Ltd. as their contribution to the PIPE Investment, and (iv) $5,102,000 from related party Material Impact Fund II, L.P. pursuant to the Securities Purchase Agreement. Material Impact Fund II, L.P. currently holds $5,102,000 of the outstanding Debentures bearing 5% interest, payable quarterly, maturing September 9, 2026, as well as holding outstanding Common Stock of the Company.
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	65192	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-10180020	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-3504002	usd
CY2023Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-10180020	usd
CY2022Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-3504002	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39765361	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9669217	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q1	kitt	Stock Options StockOptions	3472129	shares
CY2022Q1	kitt	Stock Options StockOptions	4005717	shares
CY2023Q1	kitt	Restricted And Performance Stock Units RestrictedAndPerformanceStockUnits	3169269	shares
CY2023Q1	kitt	Warrants Warrants	18722425	shares
CY2023Q1	kitt	Earnout Sharesin Shares EarnoutSharesinShares	7499993	shares
CY2022Q1	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	5299546	shares
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Nauticus Robotics, Inc.
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39765361	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9669217	shares
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2023Q1	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2085Y
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	39765361	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9669217	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2022Q1	kitt	Restricted And Performance Stock Units RestrictedAndPerformanceStockUnits		shares
CY2022Q1	kitt	Warrants Warrants		shares
CY2022Q1	kitt	Earnout Sharesin Shares EarnoutSharesinShares		shares
CY2023Q1	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable		shares
CY2022Q1	kitt	Debentures Shares DebenturesShares		shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001849820

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-23-039981-index-headers.html	Edgar Link	pending
0001213900-23-039981-index.html	Edgar Link	pending
0001213900-23-039981.txt	Edgar Link	pending
0001213900-23-039981-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_nauticusrobo.htm	Edgar Link	pending
f10q0323ex31-2_nauticusrobo.htm	Edgar Link	pending
f10q0323ex32-1_nauticusrobo.htm	Edgar Link	pending
f10q0323ex32-2_nauticusrobo.htm	Edgar Link	pending
f10q0323_nauticusrobo.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kitt-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
kitt-20230331_cal.xml	Edgar Link	unprocessable
kitt-20230331_def.xml	Edgar Link	unprocessable
kitt-20230331_lab.xml	Edgar Link	unprocessable
kitt-20230331_pre.xml	Edgar Link	unprocessable
f10q0323_nauticusrobo_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KITT
Nauticus Robotics, Inc. Stock $kitt

2023 Q2 Form 10-Q Financial Statement

#000121390023039981 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT Nauticus Robotics, Inc. Stock $kitt

2023 Q2 Form 10-Q Financial Statement

#000121390023039981 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITT
Nauticus Robotics, Inc. Stock $kitt